BELEX:DNOS Income Statement

Financials in millions RSD. Fiscal year is January - December.

Millions RSD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Premiums & Annuity Revenue	43,232	41,418	38,305	32,450	29,294	28,737
Total Interest & Dividend Income	2,855	2,492	2,143	1,870	1,290	1,284
Gain (Loss) on Sale of Investments	-149.18	-164.61	70.15	-21.16	952.4	32.37
Other Revenue	8,164	8,409	9,661	6,457	4,699	3,357
Total Revenue	54,103	52,153	50,179	40,756	36,236	33,410
Revenue Growth	6.98%	3.93%	23.12%	12.47%	8.46%	7.24%
Policy Benefits	32,617	31,252	30,350	26,052	23,036	19,452
Policy Acquisition & Underwriting Costs	9,171	8,920	7,780	8,646	8,275	6,597
Depreciation & Amortization	691.51	650.78	419.8	467.65	463.66	361.26
Selling, General & Administrative	1,920	2,089	2,071	1,253	1,260	1,499
Provision for Bad Debts	1,310	1,430	1,484	927.9	1,064	-
Other Operating Expenses	3,653	3,693	5,158	2,809	2,257	2,126
Reinsurance Income or Expense	1,608	1,629	830.46	1,697	1,444	542.47
Total Operating Expenses	49,165	47,740	47,689	39,665	36,153	30,583
Operating Income	4,938	4,413	2,490	1,091	83.12	2,827
Interest Expense	-210.26	-292.89	-351.64	-338.46	-47.03	-14.87
Currency Exchange Gain (Loss)	4.84	28.57	-29.99	142.88	-2.87	1.72
Other Non Operating Income (Expenses)	930.53	798.71	1,519	1,480	1,618	184.57
EBT Excluding Unusual Items	5,663	4,947	3,627	2,376	1,651	2,999
Gain (Loss) on Sale of Assets	342.94	140.12	105.57	408.28	-11.45	61.69
Asset Writedown	26.81	26.81	70.43	31.35	16.62	-6.41
Other Unusual Items	10.38	11.98	8.55	34.1	5.47	7.05
Pretax Income	6,043	5,126	3,812	2,850	1,662	3,061
Income Tax Expense	516.11	517.4	322.2	251.2	139.85	413.61
Earnings From Continuing Ops.	5,527	4,609	3,490	2,598	1,522	2,647
Earnings From Discontinued Ops.	-29.74	-25.23	-22.56	-20.58	-14.47	-16.41
Net Income to Company	5,497	4,584	3,467	2,578	1,508	2,631
Minority Interest in Earnings	-115.96	-72.35	-62.6	-90.34	-56.02	-36.69
Net Income	5,381	4,511	3,404	2,488	1,452	2,594
Net Income to Common	5,381	4,511	3,404	2,488	1,452	2,594
Net Income Growth	21.54%	32.51%	36.86%	71.37%	-44.05%	-28.66%
Shares Outstanding (Basic)	15	15	15	15	14	10
Shares Outstanding (Diluted)	15	15	15	15	14	10
Shares Change	-	-	3.80%	2.90%	48.31%	9.23%
EPS (Basic)	354.28	297.00	224.13	170.00	102.08	270.55
EPS (Diluted)	354.28	297.00	224.13	170.00	102.08	270.55
EPS Growth	21.54%	32.51%	31.84%	66.54%	-62.27%	-34.69%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	6,697	7,214	4,497	2,694	872.47	1,518
Free Cash Flow Per Share	440.90	474.93	296.04	184.14	61.35	158.36
Dividend Per Share	-	-	121.450	51.640	33.890	103.440
Dividend Growth	-	-	135.19%	52.38%	-67.24%	-71.24%
Operating Margin	9.13%	8.46%	4.96%	2.68%	0.23%	8.46%
Profit Margin	9.95%	8.65%	6.78%	6.10%	4.01%	7.76%
Free Cash Flow Margin	12.38%	13.83%	8.96%	6.61%	2.41%	4.54%
EBITDA	7,769	6,574	4,386	2,210	446.5	3,353
EBITDA Margin	14.36%	12.60%	8.74%	5.42%	1.23%	10.04%
D&A For EBITDA	2,831	2,161	1,896	1,118	363.38	525.61
EBIT	4,938	4,413	2,490	1,091	83.12	2,827
EBIT Margin	9.13%	8.46%	4.96%	2.68%	0.23%	8.46%
Effective Tax Rate	8.54%	10.09%	8.45%	8.82%	8.42%	13.51%